FCCC LOGO Faculty Publications
Hoppe RT , Advani RH , Ai WZ , Ambinder RF , Armand P , Bello CM , Benitez CM , Bierman PJ , Boughan KM , Dabaja B , Gordon LI , Hernandez-Ilizaliturri FJ , Herrera AF , Hochberg EP , Huang J , Johnston PB , Kaminski MS , Kenkre VP , Khan N , Lynch RC , Maddocks K , McConathy J , McKinney M , Metzger M , Morgan D , Mulroney C , Rabinovitch R , Rosenspire KC , Seropian S , Tao R , Winter JN , Yahalom J , Burns JL , Ogba N
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw. 2020 Jun;18(6) :755-781
Back to previous list
Abstract
The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. Current management of classic HL involves initial treatment with chemotherapy alone or combined modality therapy followed by restaging with PET/CT to assess treatment response. Overall, the introduction of less toxic and more effective regimens has significantly advanced HL cure rates. This portion of the NCCN Guidelines focuses on the management of classic HL.
Notes
1540-1413 Hoppe, Richard T Advani, Ranjana H Ai, Weiyun Z Ambinder, Richard F Armand, Philippe Bello, Celeste M Benitez, Cecil M Bierman, Philip J Boughan, Kirsten M Dabaja, Bouthaina Gordon, Leo I Hernandez-Ilizaliturri, Francisco J Herrera, Alex F Hochberg, Ephraim P Huang, Jiayi Johnston, Patrick B Kaminski, Mark S Kenkre, Vaishalee P Khan, Nadia Lynch, Ryan C Maddocks, Kami McConathy, Jonathan McKinney, Matthew Metzger, Monika Morgan, David Mulroney, Carolyn Rabinovitch, Rachel Rosenspire, Karen C Seropian, Stuart Tao, Randa Winter, Jane N Yahalom, Joachim Burns, Jennifer L Ogba, Ndiya Journal Article United States J Natl Compr Canc Netw. 2020 Jun;18(6):755-781. doi: 10.6004/jnccn.2020.0026.